Immune response to COVID-19 reduced in patients with blood cancers
‘Virtual biopsies’ could replace tissue biopsies in future thanks to technique developed by Cambridge scientists
6 January 2021How many people need to get a COVID-19 vaccine in order to stop the coronavirus?
6 January 2021Immune response to COVID-19 reduced in patients with blood cancers
Patients with blood cancers such as leukemia vary in their immune response to COVID-19 and can struggle to clear infection for very many weeks, according to new research published in Cancer Cell. By contrast, most patients with solid tumors, even those with advanced cancer, can mount an effective and lasting immune defense.
